Pneumocystis jirovecii pneumonia mortality risk associated with preceding long-term steroid use for the underlying disease: A multicenter, retrospective cohort study.
Kohei MiyakeSatoru SenooRitsuya ShiibaJunko ItanoGoro KimuraTatsuyuki KawaharaTomoki TamuraKenichiro KudoTetsuji KawamuraYasuharu NakaharaHisao HigoDaisuke HimejiNagio TakigawaNobuaki Miyaharanull nullPublished in: PloS one (2024)
A steroid dose before PcP onset was strongly associated with 90-day mortality in non-HIV-PcP patients, emphasizing the importance of appropriate prophylaxis especially in this population.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- antiretroviral therapy
- human immunodeficiency virus
- hiv positive
- hepatitis c virus
- hiv infected
- peritoneal dialysis
- clinical trial
- hiv testing
- hiv aids
- risk factors
- type diabetes
- men who have sex with men
- cardiovascular disease
- cross sectional
- intensive care unit
- patient reported
- double blind